Pneumococcal Vaccine
Theoretical pneumococcal vaccine coverage: analysis of serotypes isolated from inpatients at a tertiary care hospital
6
The impact of pneumococcal vaccine in reducing pneumonia hospitalizations in children under 5 years old, in Santa Catarina, Brazil, 2006 a 2014
9
Economic impact of dengue illness and the cost-effectiveness of future vaccination programs in Singapore.
9
Immunogenicity of a 23-Valent Pneumococcal Polysaccharide Vaccine in Elderly Residents of a Long-Term Care Facility
5
Immunogenicity of a 23-valent pneumococcal polysaccharide vaccine in Brazilian elderly
10
J. Pediatr. (Rio J.) vol.81 número1 en v81n1a17a
1
Progress towards meningitis prevention in the conjugate vaccines era
10
Identification of protective pneumococcal T(H)17 antigens from the soluble fraction of a killed whole cell vaccine.
7
J. Pediatr. (Rio J.) vol.88 número1 en a16v88n01
2
Pneumococcal serotypes and mortality following invasive pneumococcal disease: a population-based cohort study.
13
Sao Paulo Med. J. vol.132 número4
1
Streptococcus pneumoniae serotype distribution in Vojvodina before the introduction of pneumococcal conjugate vaccines into the national immunization program
6
Pre-vaccination nasopharyngeal pneumococcal carriage in a Nigerian population: epidemiology and population biology.
9
Scientific Institutions in Latin America : The Butantan Institute
5
Avaliação da efetividade da vacina antipneumocócica 10 valente na redução da doença pneumocócica invasiva em crianças brasileiras : estudo caso controle multicêntrico
152
Cost-Effectiveness of Vaccinating Immunocompetent ≥65 Year Olds with the 13-Valent Pneumococcal Conjugate Vaccine in England.
14
Rev. paul. pediatr. vol.34 número4
7
Phase 1 Study of an Inactivated Vaccine against American Tegumentary Leishmaniasis in Normal Volunteers in Brazil
8
Direct Comparison of Immunogenicity Induced by 10- or 13-Valent Pneumococcal Conjugate Vaccine around the 11-Month Booster in Dutch Infants.
16
Hepatitis B Vaccines and HPV Vaccines Have Been Hailed as Major Public Health Achievements in Preventing Cancer--Could a Schistosomiasis Vaccine be the Third?
3